[go: up one dir, main page]

TR201818886T4 - Dpp-iv inhibitor combined with an additional antidiabetic agent, tablets containing these formulations, their use and the process of their preparation. - Google Patents

Dpp-iv inhibitor combined with an additional antidiabetic agent, tablets containing these formulations, their use and the process of their preparation. Download PDF

Info

Publication number
TR201818886T4
TR201818886T4 TR2018/18886T TR201818886T TR201818886T4 TR 201818886 T4 TR201818886 T4 TR 201818886T4 TR 2018/18886 T TR2018/18886 T TR 2018/18886T TR 201818886 T TR201818886 T TR 201818886T TR 201818886 T4 TR201818886 T4 TR 201818886T4
Authority
TR
Turkey
Prior art keywords
dpp
preparation
formulations
tablets containing
antidiabetic agent
Prior art date
Application number
TR2018/18886T
Other languages
Turkish (tr)
Inventor
Friedl Thomas
Braun Michael
Egusa Kenji
Fujita Hikaru
Maruyama Megumi
Nishioka Takaaki
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=66630027&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR201818886(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of TR201818886T4 publication Critical patent/TR201818886T4/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Bu buluş, bir DPP-4 inhibitörü ilacı ile bir partner ilacın sabit doz kombinasyonlarını içeren farmasötik bileşimlerle, bunları hazırlama amacına yönelik proseslerle ve bunların belirli hastalıkların tedavisinde kullanılmalarıyla ilgilidir.The present invention relates to pharmaceutical compositions comprising fixed dose combinations of a DPP-4 inhibitor drug and a partner drug, processes for their preparation, and their use in the treatment of certain diseases.

TR2018/18886T 2008-04-03 2009-04-02 Dpp-iv inhibitor combined with an additional antidiabetic agent, tablets containing these formulations, their use and the process of their preparation. TR201818886T4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08154039 2008-04-03
US8734308P 2008-08-08 2008-08-08

Publications (1)

Publication Number Publication Date
TR201818886T4 true TR201818886T4 (en) 2019-01-21

Family

ID=66630027

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2018/18886T TR201818886T4 (en) 2008-04-03 2009-04-02 Dpp-iv inhibitor combined with an additional antidiabetic agent, tablets containing these formulations, their use and the process of their preparation.

Country Status (3)

Country Link
CL (1) CL2009000809A1 (en)
HU (1) HUE041649T2 (en)
TR (1) TR201818886T4 (en)

Also Published As

Publication number Publication date
CL2009000809A1 (en) 2010-04-09
HUE041649T2 (en) 2019-05-28

Similar Documents

Publication Publication Date Title
MX351232B (en) Dpp-iv inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation.
CY1118661T1 (en) PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL DOSAGE FORM, PROCEDURE FOR THEIR PREPARATION, METHODS FOR TREATMENT AND USE OF THESE
ECSP088974A (en) IMIDAZOL PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF DISEASES RELATED TO THE SYNTHEOSE QUINASA GLYCOGEN (GSK3)
MX2012012438A (en) Pharmaceutical formulations comprising pioglitazone and linagliptin.
MX384206B (en) DPP IV INHIBITOR FORMULATIONS
MX2009006704A (en) New compounds.
BRPI0916668A2 (en) c5 complement protein targeting antibody compositions and methods
BRPI0915084B8 (en) compound, and, pharmaceutical composition
SV2010003451A (en) PIRIMIDINE DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES
MX374797B (en) PHARMACEUTICAL FORMULATIONS CONTAINING DAPAGLIFLOZIN PROPYLENE GLYCOL HYDRATE.
EA200901138A1 (en) DERIVATIVES OF DIANILINOPYRIMIDINE AS KEEIN INHIBITORS WEE1, PHARMACEUTICAL COMPOSITION AND USE
CR11455A (en) NEW CYCL HYDROCARBON COMPOUNDS FOR THE TREATMENT OF DISEASES
ECSP088904A (en) ARILIMIDAZOLONAS AND ARILTRIAZOLONAS REPLACED AS INHIBITORS OF VASOPRESINE RECEPTORS
UY30759A1 (en) CHEMICAL COMPOUNDS
CL2007001166A1 (en) Compounds derived from condensed pyrimidine, pi3-kinase inhibitors; processes to prepare the compounds; pharmaceutical composition that includes them; use of the compounds in the preparation of medicaments; process to prepare the pharmaceutical composition; and kit that includes the pharmaceutical composition
EA201070421A1 (en) MICRORIPONIC ACID
MX347525B (en) Inhibitors of bruton's tyrosine kinase.
UA104988C2 (en) Novel pyrone-indole derivatives and process for their preparation
EA201171497A1 (en) REDUCTION OF OPIOID FLUCTUATIONS IN THE BLOOD
MX2012005689A (en) Arachidonic acid analogs and methods for analgesic treatment using same.
WO2009099553A3 (en) Use of kinase inhibitor in treatment of atherosclerosis
CL2009001267A1 (en) Compounds derived from nitrogenous tricycles, with antibacterial activity; preparation procedure; pharmaceutical composition comprising them; for the treatment of tuberculosis.
CL2007003251A1 (en) Compounds derived from substituted 1H-pyrazoles, inhibitors of kinase-catalyzed reactions; its preparation procedure; pharmaceutical composition; intermediate compounds; use of the main compounds, useful in the treatment of cancer.
GB201014391D0 (en) Drug composition and its use in therapy
EA201171414A1 (en) IAP FAMILY INHIBITORS